Type 2 diabetes mellitus: Quality prescribing strategy - a guide for improvement
Understand your system - the processes, people and how they interact with each other. This helps identify the changes required and the impact they might have elsewhere in the system.
Suggested actions - understanding systems
Health boards
- Is this a clinical priority for the health board? If not, why not?
- Does the board have an identified clinical lead for this?
Managed Clinical Network (MCN) and Respiratory Specialists in secondary care
- Is the MCN aware of the guidelines and ready to lead by example in implementing these?
- Does the MCN link with local groups of people and can these be developed locally?
Clusters and Cluster Quality Leads (CQLs)
- Have the CQLs and clusters reviewed the recently published cluster reports?
- Are the clusters willing to work together to share experience and learning and work together to focus implementation on this area?
GP Practices and Primary Care Team
- Is there a clinical lead within the practice for T2DM? Is this the sole practitioner managing these people?
- How does the practice direct/support the prescribing of others in the practice for the benefit of those living with T2DM? How do patient groups link with this?
Engage with key stakeholders
How will you engage with patient groups, wider MDT, community link workers/third sector groups to co-design your approach?
